Custom service

Peptide-oligonucleotide Conjugation

Join peptides and oligonucleotides into single, well-defined molecules

Turnaround: 4–6 weeksTypical scale: 0.1–50 mg conjugate per batchChemistry options: maleimide–thiol ligation; CuAAC click chemistry on alkyne oligonucleotides; Staudinger ligation for reduction-sensitive payloads

Peptide-oligonucleotide Conjugation supports programmes that join peptides and oligonucleotides into single, well-defined molecules. In a typical engagement we plan the maleimide–thiol ligation route first, confirm compatibility with CuAAC click chemistry on alkyne oligonucleotides, and release purified conjugate with ESI-MS identity confirmation on a 4–6 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep maleimide–thiol ligation as the primary option and hold CuAAC click chemistry on alkyne oligonucleotides in reserve, so that scale-up never depends on an unproven step.

qPCR probe and antisense constructs

SERS and electrochemical biosensor interfaces

Plasmid- or fragment-scale nucleic acid payloads

Conjugates whose payload cannot tolerate aqueous coupling conditions

Every conjugation batch is documented from vial to vial: carrier lot, payload lot, reagent lots, reaction conditions and purification chromatograms. The release package contains the loading ratio measured by an orthogonal method (UV, ICP-MS or amino-acid analysis), identity by mass spectrometry where the conjugate permits it, and residual-free-payload data.

Service Highlights

  • Maleimide–thiol ligation as the default route, with CuAAC click chemistry on alkyne oligonucleotides held as a proven fallback
  • Staudinger ligation for reduction-sensitive payloads worked into the design where the application requires it
  • Carrier and payload compatibility screened in a small feasibility batch before full material is committed
  • Analytical confirmation of every intermediate before the final release
  • Unreacted payload driven below the detection limit of the release assay before purification is closed
  • Purified conjugate with ESI-MS identity confirmation delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Scope & design

    We review the payload, the carrier and the intended assay or study, and propose between maleimide–thiol ligation and CuAAC click chemistry on alkyne oligonucleotides as candidate routes.

  2. Feasibility screen

    A milligram-scale screen compares loading, residual payload and activity across the candidate conditions.

  3. Production conjugation

    The selected condition is executed at project scale with in-process sampling at fixed time points.

  4. Purification

    Size-exclusion, dialysis or magnetic separation removes free payload and by-products.

  5. Characterization & release

    Identity, loading ratio and functional activity are measured against the agreed specification.

  6. Documentation & hand-off

    Purified conjugate with ESI-MS identity confirmation is packaged with the full batch record, released for shipment after QC sign-off.

Specifications & timeline

Turnaround
4–6 weeks
Typical scale
0.1–50 mg conjugate per batch
Chemistry options
maleimide–thiol ligation; CuAAC click chemistry on alkyne oligonucleotides; Staudinger ligation for reduction-sensitive payloads
Deliverable
Purified conjugate with ESI-MS identity confirmation
QC package
HPLC/SEC trace, MALDI-TOF or ESI-MS, UV/Vis or ICP-MS loading ratio
Shipping
Blue ice or dry ice as the payload requires, with a cold-chain manifest

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.